Clinical Trial Update: Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating whether colchicine can affect the progression of non-flow-limiting coronary plaque detected by coronary CT angiography in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Coronary Artery Disease (CAD) | Phase 4 | Status: RECRUITING